Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia
Open accessThe DOI matches its Crossref record; 263 of the 263 references it cites were found in a registry or an index.
Abstract
In subjects with schizophrenia, impairments in working memory are associated with dysfunction of the dorsolateral prefrontal cortex (DLPFC). This dysfunction appears to be due, at least in part, to abnormalities in gamma-aminobutyric acid (GABA)-mediated inhibitory circuitry. To test the hypothesis that altered GABA-mediated circuitry in the DLPFC of subjects with schizophrenia reflects expression changes of genes that encode selective presynaptic and postsynaptic components of GABA neurotransmission, we conducted a systematic expression analysis of GABA-related transcripts in the DLPFC of 14 pairs of schizophrenia and age-, sex- and post-mortem interval-matched control subjects using a customized DNA microarray with enhanced sensitivity and specificity. Subjects with schizophrenia exhibited expression deficits in GABA-related transcripts encoding (1) presynaptic regulators of GABA neurotransmission (67 kDa isoform of glutamic acid decarboxylase (GAD(67)) and GABA transporter 1), (2) neuropeptides (somatostatin (SST), neuropeptide Y (NPY) and cholecystokinin (CCK)) and (3) GABA(A) receptor subunits (alpha1, alpha4, beta3, gamma2 and delta). Real-time qPCR and/or in situ hybridization confirmed the deficits for six representative transcripts tested in the same pairs and in an extended cohort, respectively. In contrast, GAD(67), SST and alpha1 subunit mRNA levels, as assessed by in situ hybridization, were not altered in the DLPFC of monkeys chronically exposed to antipsychotic medications. These findings suggest that schizophrenia is associated with alterations in inhibitory inputs from SST/NPY-containing and CCK-containing subpopulations of GABA neurons and in the signaling via certain GABA(A) receptors that mediate synaptic (phasic) or extrasynaptic (tonic) inhibition. In concert with previous findings, these data suggest that working memory dysfunction in schizophrenia is mediated by altered GABA neurotransmission in certain DLPFC microcircuits.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“an expression analysis of DLPFC from SZ patients indicated the reduced expression of several GABA-related genes, including neuropeptides and both presynaptic and postsynaptic markers 183.”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [183]
In the citing paper
“Despite variable results, consistent findings across studies can be identified, including dysregulation of GABAergic signalling102; downregulation of oligodendrocyte- and myelination-related genes103, mitochondrial function or energy metabolism104, and synaptic genes105; and upregulation of immune and inflammatory genes106.”
From Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders (2015) · cites this paper as [102]
Citations
Cites
Items 201–263 of 263
Cellerino, A., Maffei, L., & Domenici, L. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01287.x · Cited by 107
Eastwood, S. L., & Harrison, P. J. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.07.001 · Cited by 106
Glorioso, C. A., Sabatini, M., Unger, T. L., Hashimoto, T., Monteggia, L. M., Lewis, D. A., & Mirnics, K. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001835 · Cited by 105
Self-citationRat hippocampal GABAergic molecular markers are differentially affected by ageing
Vela, J., Gutierrez, A., Vitorica, J., & Ruano, D. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01681.x · Cited by 100
Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex
Gabriel, S. M., Davidson, M. H., Haroutunian, V. H., Powchik, P., Bierer, L. M., Purohit, D. P., Perl, D. P., & Davis, K. L. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00066-6 · Cited by 97
Carving Chaos: Genetics and the Classification of Mood and Psychotic Syndromes
Potash, J. B. (2006) · Harvard Review of Psychiatry · doi:10.1080/10673220600655780 · Cited by 96
Vaucher, E., Tong, X., Cholet, N., Lantin, S., & Hamel, É. (2000) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(20000529)421:2<161::aid-cne3>3.3.co;2-6 · Cited by 96
Comparative genome‐ and proteome analysis of cerebral cortex from MK‐801‐treated rats
Paulson, L., Martin, P., Persson, A., Nilsson, C. L., Ljung, E., Westman‐Brinkmalm, A., Eriksson, P. S., Blennow, K., & Davidsson, P. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10509 · Cited by 95
Wirth, M. J., Brün, A., Grabert, J., Patz, S., & Wahle, P. (2003) · Development · doi:10.1242/dev.00826 · Cited by 92
De Lima, A. D., & Morrison, J. H. (1989) · Journal of Comparative Neurology · doi:10.1002/cne.902830205 · Cited by 91 · cited 5×
“, 2006) and target distal dendritic shafts of pyramidal cells (Hendry et al., 1984; DeLima and Morrison, 1989; Kawaguchi and Kubota, 1996; Melchitzky and Lewis, 2008).”
BackgroundInfluentialThree classes of GABAergic interneurons in neocortex and neostriatum.
Kubota, Y., & Kawaguchi, Y. (1994) · PubMed · Cited by 88
Reduced neuropeptide Y mRNA expression in the prefrontal cortex of subjects with bipolar disorder
Caberlotto, L., & Hurd, Y. L. (1999) · NeuroReport · doi:10.1097/00001756-199906030-00022 · Cited by 86
Kempf, L., Hussain, N., & Potash, J. B. (2005) · International Review of Psychiatry · doi:10.1080/09540260500064959 · Cited by 82
Melchitzky, D. S. (2003) · Cerebral Cortex · doi:10.1093/cercor/13.5.452 · Cited by 82
Cultured Hippocampal Pyramidal Neurons Express Two Kinds of GABAA Receptors
Mangan, P. S., Sun, C., Carpenter, M., Goodkin, H. P., Sieghart, W., & Kapur, J. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.007385 · Cited by 81
Somatostatin Increases a Voltage-Insensitive K+Conductance in Rat CA1 Hippocampal Neurons
Schweitzer, P., Madamba, S. G., & Siggins, G. R. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.79.3.1230 · Cited by 81
The bipolar disorder phenome database: a resource for genetic studies
Potash, J. B., Toolan, J., Steele, J., Miller, E. B., Pearl, J., Zandi, P. P., Schulze, T. G., Kassem, L., Simpson, S. G., Lopez, V., et al. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06122045 · Cited by 80 · cited 1×
“6 many putative susceptibility genes (Potash, 2006; Potash et al., 2007).”
BackgroundPalizvan, M. R., Sohya, K., Kohara, K., Maruyama, A., Yasuda, H., Kimura, F., & Tsumoto, T. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.03.053 · Cited by 79
Gonzalez-Albo, M. C. (2001) · Cerebral Cortex · doi:10.1093/cercor/11.12.1170 · Cited by 77
Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenics
Bachus, S. E., Hyde, T. M., Herman, M. M., Egan, M. F., & Kleinman, J. E. (1997) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(96)00041-6 · Cited by 75
Expression of five somatostatin receptor mRNAs in the human brain and pituitary
Thoss, V. S., P�rez, J., Probst, A., & Hoyer, D. (1996) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00168430 · Cited by 75
Evidence for Sustained Attention and Working Memory in Schizophrenia Sharing a Common Mechanism
Silver, H. (2005) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.17.3.391 · Cited by 74
Caberlotto, L., Fuxé, K., & Hurd, Y. L. (2000) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(00)00107-1 · Cited by 74
Kohara, K., Kitamura, A., Adachi, N., Nishida, M., Itami, C., Nakamura, S., & Tsumoto, T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-14-06123.2003 · Cited by 73
Glantz, L. A., Austin, M. C., & Lewis, D. A. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00923-9 · Cited by 71
Self-citationHervieu, G. J., & Emson, P. C. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00024-4 · Cited by 70
Impaired working memory monitoring in euthymic bipolar patients
Thompson, J. M., Gray, J. M., Hughes, J. H., Watson, S., Young, A. H., & Ferrier, I. N. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00470.x · Cited by 70
Effects of BDNF and NT‐4/5 on Striatonigral Neuropeptides or Nigral GABA Neurons In Vivo
Arenas, E., Åkerud, P., Wong, V., Boylan, C., Person, H., Lindsay, R. M., & Altar, C. A. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01314.x · Cited by 67
Melchitzky, D. S., & Lewis, D. A. (2008) · Synapse · doi:10.1002/syn.20514 · Cited by 66
Self-citationQin, Z., Zhang, S., & Weiss, B. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90260-7 · Cited by 60
Videau, C., Hochgeschwender, U., Kreienkamp, H., Brennan, M. B., Viollet, C., Richter, D., & Epelbaum, J. (2003) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-003-0758-8 · Cited by 58
Möller-Leimkühler, A. M. (2005) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-005-0619-1 · Cited by 58
Transcriptional Signatures of Cellular Plasticity in Mice Lacking the α1 Subunit of GABAAReceptors
Ponomarev, I., Maiya, R., Harnett, M. T., Schafer, G. L., Ryabinin, A. E., Blednov, Y. A., Morikawa, H., Boehm, S. L., Homanics, G. E., Berman, A., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0860-06.2006 · Cited by 54
Delalle, I., Evers, P., Kostovi?, I., & Uylings, H. B. M. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19970324)379:4<515::aid-cne4>3.0.co;2-5 · Cited by 53
Synaptic targets of calretinin-containing axon terminals in macaque monkey prefrontal cortex
Melchitzky, D. S., Eggan, S. M., & Lewis, D. A. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.08.046 · Cited by 52
Self-citationEffects of Neurotrophins on Synaptic Protein Expression in the Visual Cortex of Dark-Reared Rats
Cotrufo, T., Viegi, A., Berardi, N., Bozzi, Y., Mascia, L., & Maffei, L. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-09-03566.2003 · Cited by 52
Cholecystokinin messenger RNA deficit in frontal and temporal cerebral cortex in schizophrenia
Virgo, L., Humphries, C., Mortimer, A. M., Barnes, T. R. E., Hirsch, S. R., & de Belleroche, J. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00206-i · Cited by 51
Platform influence on DNA microarray data in postmortem brain research
Hollingshead, D. J., Lewis, D. A., & Mirnics, K. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.10.020 · Cited by 50
Self-citationHuang, X., Deng, C., & Zavitsanou, K. (2006) · Neuropeptides · doi:10.1016/j.npep.2006.01.002 · Cited by 50
Stolovitzky, G. A., Kundaje, A. B., Held, G. A., Duggar, K., Haudenschild, C. D., Zhou, D., Vasicek, T. J., Smith, K. D., Aderem, A. A., & Roach, J. C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406555102 · Cited by 50
Dournaud, P., Cervera, P., Hirsch, É. C., Javoy-Agid, F., Kordon, C., Agid, Y., & Epelbaum, J. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90399-9 · Cited by 48
Transcriptional Regulation of Cortical Interneuron Development: Figure 1.
Butt, S. J. B., Cobos, I., Golden, J., Kessaris, N., Pachnis, V., & Anderson, S. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3525-07.2007 · Cited by 47
Huntley, G. W., Vickers, J. C., & Morrison, J. H. (1997) · Brain Research · doi:10.1016/s0006-8993(96)00847-5 · Cited by 47 · cited 1×
“In the primate cortex, approximately 50-90% of PVcontaining, but only 10% of CR-containing neurons were immunoreactive for the NR1 subunit of the NMDA receptor (Huntley et al., 1994; Huntley et al., 1997).”
BackgroundUylings, H. B. M., & Delalle, I. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19970324)379:4<523::aid-cne5>3.0.co;2-4 · Cited by 46
Lepre, J., Rice, J. J., Tu, Y., & Stolovitzky, G. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth035 · Cited by 43
Sakai, K., Maeda, K., Chihara, K., & Kaneda, H. (1995) · Neuropeptides · doi:10.1016/0143-4179(95)90018-7 · Cited by 42
Schwab, S. G., Wildenauer, D. B., Collier, D. A., Ekelund, A., Gejman, P., Hallmayer, J., Kelsoe, J. R., von Gontard, A., & Wildenauer, D. B. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990618)88:3<276::aid-ajmg13>3.0.co;2-n · Cited by 42
Chromosomes 12 and 16 workshop
Detera-Wadleigh, S. D., Barden, N., Craddock, N., Ewald, H., Foroud, T., Kelsoe, J., & McQuillin, A. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990618)88:3<255::aid-ajmg8>3.0.co;2-v · Cited by 40
Comprehensive Gene Expression Analysis in Bipolar Disorder
Kato, T., Kakiuchi, C., & Iwamoto, K. (2007) · The Canadian Journal of Psychiatry · doi:10.1177/070674370705201203 · Cited by 36
Hayes, T. L., Cameron, J. L., Fernstrom, J. D., & Lewis, D. A. (1991) · Journal of Comparative Neurology · doi:10.1002/cne.903030406 · Cited by 32
Self-citationVilluendas, G., Sánchez‐Franco, F., Palacios, N., Fernández, M., & Cacicedo, L. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00177-2 · Cited by 28
da Cunha, A., Rausch, D. M., & Eiden, L. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1371 · Cited by 26
Unger, T. L., Korade, Ž., Lazarov, O., Terrano, D. T., Sisodia, S. S., & Mirnics, K. (2005) · Methods · doi:10.1016/j.ymeth.2005.09.005 · Cited by 22
Self-citationHund‐Georgiadis, M., Ballaschke, O., Scheid, R., Norris, D. G., & von Cramon, D. Y. (2002) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10039 · Cited by 21
Postnatal changes in enzyme activities of rat myocardial adenine nucleotide catabolic pathway
Wang, T., Tan, Z.-T., & Webb, W. R. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90338-9 · Cited by 19
Gene dosage effect of the TrkB receptor on rod physiology and biochemistry in juvenile mouse retina.
Rohrer, B. (2001) · PubMed · Cited by 19
Marcus, M. M., Nomikos, G. G., Malmerfelt, A., Zachrisson, O., Lindefors, N., & Svensson, T. H. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00263-x · Cited by 13
Bacci, J., Salin, P., & Goff, L. K. (2002) · Synapse · doi:10.1002/syn.10117 · Cited by 12
Diagnosing schizophrenia circa 2005: How and why?
McCormick, L. M., & Flaum, M. A. (2005) · Current Psychiatry Reports · doi:10.1007/s11920-005-0086-4 · Cited by 12
Cahir, M., Costello, I., King, D. J., & Reynolds, G. P. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.09.057 · Cited by 12
In vivo electrical activity of brainstem neurons in fetal rats during asphyxia
Sakata, Y., Fujioka, T., Chowdhury, G. M. I., & Nakamura, S. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02456-2 · Cited by 10
Effect of haloperidol withdrawal on somatostatin level and binding in rat brain
Perez-Oso, E., López-Ruiz, M. P., & Arilla, E. (1990) · Bioscience Reports · doi:10.1007/bf01116846 · Cited by 8
Martinez-Ferrer, A. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00095-6 · Cited by 5
Research works printed but not linked: 2
- Melchitzky DS, Lewis DA . Synaptic targets of somatostatin-labeled axon terminals in monkey prefrontal cortex. Soc Neurosci Abstr 2005; 675: 6.
- Kim AM, Matzilevich DA, Walsh JP, Benes FM, Woo TW . Parvalbumin-containing neurons and disturbances of prefrontal cortical circuitry in schizophrenia. Soc Neurosci Abstr 2005; 912: 1.
Cited by
Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,914
Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia
Lewis, D. A., Curley, A. A., Glausier, J. R., & Volk, D. W. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.10.004 · Cited by 1,071
Self-citationModelling neural correlates of working memory: A coordinate-based meta-analysis
Rottschy, C., Langner, R., Dogan, I., Reetz, K., Laird, A. R., Schulz, J. B., Fox, P. T., & Eickhoff, S. B. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.11.050 · Cited by 951
Gonzalez-Burgos, G., & Lewis, D. A. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn070 · Cited by 577
Self-citationShelton, R. C., Claiborne, J., Sidoryk-Wegrzynowicz, M., Reddy, R., Aschner, M., Lewis, D. A., & Mirnics, K. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.52 · Cited by 511
Self-citation
Metadata
- Authors
- Hashimoto, T., Arion, D., Unger, T., Maldonado-Avilés, J. G., Morris, H. M., Volk, D. W., Mirnics, K., & Lewis, D. A.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Lewis, D A
- Venue
- Molecular Psychiatry
- Published
- 2007-05-01
- Volume
- 13
- Issue
- 2
- Pages
- 147-161
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- PMC
- PMC2882638
- OpenAlex
- W2126843605
- Cited by
- 490
- References
- 262
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 17 · 2023: 17 · 2022: 15 · 2021: 24 · 2020: 29 · 2019: 22 · 2018: 26 · 2017: 25 · 2016: 33 · 2015: 42 · 2014: 25 · 2013: 29 · 2012: 27
- FWCI
- 20.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Eli Lilly and Company
- National Institutes of Health
- Medical Center, University of Pittsburgh
- National Institute of Mental Health (R01MH043784, MH43784, MH 45156, MH-067234, MH070786, K02MH070786, R01MH067234, P50MH045156, R37MH043784)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P30HD015052)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- schizophrenia, dorsolateral prefrontal cortex, GABAergic neurotransmission, gene expression, working memory, GAD67, GABA transporter 1, somatostatin, neuropeptide Y, cholecystokinin, GABAA receptor subunits, presynaptic inhibition, tonic inhibition, antipsychotic exposure, inhibitory interneurons
- MeSH terms
- Olanzapine, Adult, Aged, Animals, Benzodiazepines, Chloroquinolinols, Female, Gene Expression Regulation, Glutamate Decarboxylase, Humans, Macaca fascicularis, Male, Middle Aged, Neuropeptides, Receptors, GABA-A, Schizophrenia, Antipsychotic Agents, Case-Control Studies, Prefrontal Cortex, Oligonucleotide Array Sequence Analysis, Protein Subunits, GABA Plasma Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.